The deaths of millions of people worldwide could lead the hyperlobes and cost no more or more than 2 trillion. dollars in the world economy annually by 2050, as the Guardian reports.

In particular, a survey funded by the UK government shows that without coordinated action, increased percentages of antimicrobial drugs (AMR) could lead to global annual GDP losses of 1.7 trillion. dollars in the next quarter of the century.

The cuts the cause behind the dangerous ‘super’ germs

His investigation Center for Global Development (Center for Global Development) has found that US, United Kingdom and EU economies will be more affected, resulting in accusations that recent large cuts are self -destructive.

For example, on Thursday, the UK government announced that it is abolishing fleming fund funding.

The Fleming Fund is a UK targeted development program under the direction of the Ministry of Health and Social Care, with a budget of about 265 million pounds from 2015 to 2025, to combat germs that have been resistant to AMR and AMR and AMR. income.

OR Trump government It has confirmed cuts of $ 9 billion in its budget to assistance to foreign countries, while many European countries have also reduced the costs of giving assistance to other distant countries.

Bell expert for immediate action

Anthony McDonnell, head of research and policymaker at the Center for Global Development, said: “When we conducted our research on the economic effects of the increasing appearance of germs’ resistance to antimicrobial drugs, it was expected that the percentages of more resistant germs would continue to follow historical trends.

However, the Sudden cuts of official US development aidwhich reduced their expenditure to provide aid by about 80%, the United Kingdom, which announced aid cuts from 0.5% to 0.3% of gross national income, as well as significant reductions from France, Germany and other countries, could lead to increased rates of our research“

“Even the countries that have succeeded in keeping AMR rates under control cannot rest. If AMR programs are not protected from funding cuts, resilient rates worldwide will grow rapidly“, He added.

“This will result in millions of more people worldwide dying, including G7 countries. Investing in the treatment of bacterial infections now will save lives and bring billions to long -term financial returns“, Said Mr McDonnell.

A lot of money and many lives are at stake

The research calculated the financial burden and the health burden on the most resistant germs in antibiotics for 122 countries and predicted that in this most pessimistic scenario, by 2050, GDP losses in China could reach $ 29 billion in $ 295. $ 65.7 billion and in the United Kingdom $ 58.6 billion.

According to the Institute of Health Measurement and Evaluation (IHME), deaths due to antibiotic resistance to antibiotics are expected to increase by 60% by 2050, with 1.34 million people in the US and 184,000 only in the United Kingdom to be predicted to die each year from antibiotics. Medication resistant is also expected to increase.

“Super” germs increase the number of hospital admissions and lead to longer duration and more intensive hospital monitoring, more expensive treatments and more complex care, which means that resistant infections are about twice as high as the cost of treatment.